Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices

Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices

These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of toxicology. Clinical toxicology 2001, Vol.39 (1), p.85-100
Format: Artikel
Sprache:eng
Schlagworte:
Adult
aluminum hydroxide
Animals
Anthrax - immunology
Anthrax - prevention & control
Anthrax Vaccines - administration & dosage
Anthrax Vaccines - adverse effects
Anthrax Vaccines - therapeutic use
Bacillus anthracis
Bacteriology
Biological and medical sciences
Child
Fundamental and applied biological sciences. Psychology
Humans
Immunity, Cellular
Injections, Intramuscular
Injections, Subcutaneous
Microbiology
United States
USA
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed [AVA], BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.
ISSN:0731-3810
1097-9875
DOI:10.1081/CLT-100102886